Clinical and Laboratory Characteristics of Chronic Natural Killer Cell Lymphocytosis

To the Editor:
We read with interest the report of Tefferi et al' describing the clinical features of chronic natural killer (NK) cell lymphocytosis. They studied 10 patients in detail and concluded that the condition was slightly more common in males, was associated with pure red blood cell aplasia and recurrent neutropenia, and showed a chronic 'benign' clinical course. They also made a comparison with T-cell large granular lymphocytic leukemia and reported that both conditions showed similar epidemiologic and clinical features. The only differences they noted were lesser incidences of anemia and neutropenia in patients with chronic NK cell lymphocytosis and a higher incidence (26%) of rheumatoid arthritis in patients with T-cell large granular lymphocytosis (T-LGL) leukemia. It is interesting to note that our analysis of a somewhat larger patient group (26 patients with chronic NK cell lymphocytosis, 43 cases of persistent T-LGL, and 23 patients with mixed expansions [both CD3-and CD3' populations] shows, except for a female predominance in the chronic NK cell lymphocytosis group (F:M, 3:1), a strikingly similar finding (Table 1 ). This provides further evidence to our assertion that immunophenotype of the abnormally expanded populations may not per se have a direct relationship with either the manifestations or the clinical course of the conditions. However, we would like to present the data of comparisons made between the various categories, defined by the immunophenotype of the predominant cell population(s), because we believe that our findings will supplement the data provided by Tefferi et al. ' Our data show that there were no significant differences in the incidences of associated clinical conditions or laboratory abnormalities except T-cell receptor gene rearrangements, which were not demonstrated in any of the CD3-proliferations. Similar to the findings of Tefferi et al,' rheumatoid arthritis, anemia, and neutropenia were more commonly associated with T-LGL, although the differences were not statistically significant. It should be noted that our CD3' group included both clonal and nonclonal proliferations, whereas that of Tefferi et al.' was uniformly clonal. This difference may explain the higher incidence of anaemia (51%) and neutropenia (74%) recorded in their cohort and documented in their earlier report5 The morphologic characteristics, ie, LGL morphology and BLT esterase positivity (benzylcarbonyl-L-lysine thiobenzyl esterase), were also not different between the CD3' and CD3-proliferations, probably indicating that the morphologic features of these cells may not be directly related to the surface immunophenotype or genotype.
The clinical course of the patients in our cohort also showed marked resemblance to that described by Tefferi et al.' All of the patients are alive after a follow-up period of 4 years with no sign of disease progression as indicated by the degree of peripheral blood lymphocytosis, the severity of cytopenias, or organ infiltration.
As indicated in their report, a minor proportion of the chronic NK cell lymphocytosis may be clonal, as demonstrated by X-linked DNA analysis-a finding similar to that of ours! The X-inactivation analysis of the phosphoglycerate kinase (PGK) gene in six polymorphic female patients showed that two cases were clonal proliferations (9%). The incidence of demonstrable clonal proliferation in their cohort was 10%.
Based on the findings of these two studies, it would seem reasonable to conclude that the condition chronic NK lymphocytosis exhibit similar clinical and laboratory features to the more common T-LGL and has an indolent course. 
